Risk for permanent pacemaker after transcatheter aortic valve implantation: A comprehensive analysis of the literature

Journal of Cardiovascular Electrophysiology

Volumn 23, Issue 4, 2012, Pages 391-397

  Erkapic, Damir ^a   De Rosa, Salvatore ^a   Kelava, Augustin ^b   Lehmann, Ralf ^a   Fichtlscherer, Stephan ^a   Hohnloser, Stefan H ^a  

^a GOETHE UNIVERSITY   (Germany)

^b DARMSTADT UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

aortic stenosis; CoreValve prosthesis; Edwards Sapiens prosthesis; heart block; pacemaker; TAVI; trans catheter aortic valve implantation

Indexed keywords

ARTICLE; ARTIFICIAL HEART PACEMAKER; ATRIOVENTRICULAR BLOCK; HEART RIGHT BUNDLE BRANCH BLOCK; HUMAN; PATIENT MONITORING; PRIORITY JOURNAL; RISK; RISK ASSESSMENT; SYSTEMATIC REVIEW; TRANSCATHETER AORTIC VALVE IMPLANTATION;

AGED; AGED, 80 AND OVER; AORTIC VALVE STENOSIS; ATRIOVENTRICULAR BLOCK; BUNDLE-BRANCH BLOCK; CARDIAC PACING, ARTIFICIAL; CHI-SQUARE DISTRIBUTION; EVIDENCE-BASED MEDICINE; FEMALE; HEART CATHETERIZATION; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; MALE; ODDS RATIO; PACEMAKER, ARTIFICIAL; PROSTHESIS DESIGN; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84860109064     PISSN: 10453873     EISSN: 15408167     Source Type: Journal    
DOI: 10.1111/j.1540-8167.2011.02211.x     Document Type: Article

References (44)

1. Nkomo VT, Gardin JM, Skelton TN, Gottdiener JS, Scott CG, Enriquez- Sarano M,: Burden of valvular heart diseases: A population-based study. Lancet 2006; 368: 1005-1011.
2. Baumgartner H, Bonhoeffer P, De Groot NMS, de Haan F, Deanfield JE, Galie N, Gatzoulis MA, Gohlke-Baerwolf C, Kaemmerer H, Kilner P, Meijboom F, Mulder BJM, Oechslin E, Oliver JM, Serraf A, Szatmari A, Thaulow E, Vouhe PR, Walma E,: ESC guidelines for the management of grown-up congenital heart disease (new version 2010). Eur Heart J 2010; 31: 2915-2957.
3. Vahanian A, Alfieri O, Al-Attar N, Antunes M, Bax J, Cormier B, Cribier A, De Jaeqere P, Fournial G, Kappetein AP, Kovac J, Ludgate S, Maisona F, Moat N, Mohr F, Nataf P, Pierard L, Pomar JL, Schofer J, Tornos P, Tuzcu M, van Hout B, von Segesser LK, Walther T,: Trans-catheter valve implantation for patients with aortic stenosis: A position statement from the European Association of Cardio-Thoracic Surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Cardiovascular Interventions (EAPCI). EuroIntervention 2008; 4: 193-199.
4. Cribier A, Eltchaninoff H, Bash A, Borenstein N, Tron C, Bauer F, Derumeaux G, Anselme F, Laborde F, Leon MB,: Percutaneous trans-catheter implantation of an aortic valve prosthesis for calcific aortic stenosis: First human case description. Circulation 2002; 106: 3006-3008.
5. Borenstein M, Hedges L, Higgins J, Rothenstein HR,: Computing Effect Sizes for Meta-Analysis. Chirchester: John Wiley & Sons, Ltd; 2009.
6. Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF, QUOROM Group: Improving the quality of reports of meta-analyses of randomized controlled trials: The QUOROM statement. Lancet 1999; 354: 1896-1900.
7. DerSimonian R, Laird N,: Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-188.
8. Thompson SG, Sharp SJ,: Explaining heterogeneity in meta-analysis: A comparison of methods. Stat Med 1999; 18: 2693-2708.
9. Fraccaro C, Buja G, Tarantini G, Gasparetto V, Leoni L, Razzolini R, Corrado D, Bonato R, Basso C, Thiene G, Gerosa G, Isabella G, Iliceto S, Napodano M,: Incidence, predictors, and outcome of conduction disorders after transcatheter self-expandable aortic valve implantation. Am J Cardiol 2011; 107: 747-754.
10. Jahangiri M, Laborde JC, Roy D, Williams F, Abdulkareem N, Brecker S,: Outcome of patients with aortic stenosis referred to a multidisciplinary meeting for transcatheter valve. Ann Thorac Surg 2011; 91: 411-5.
11. Johansson M, Nozohoor S, Kimblad PO, Harnek J, Olivecrona GK, Sjögren J,: Transapical versus transfemoral aortic valve implantation: A comparison of survival and safety. Ann Thorac Surg 2011; 91: 57-63.
12. Kodali SK, O'Neill WW, Moses JW, Williams M, Smith CR, Tuzcu M, Svensson LG, Kapadia S, Hanzel G, Kirtane AJ, Leon MB,: Early and late (one year) outcomes following transcatheter aortic valve implantation in patients with severe aortic stenosis (from the United States REVIVAL trial). Am J Cardiol 2011; 107: 1058-1064.
13. Koos R, Mahnken AH, Aktug Ö, Dohmen G, Autschbach R, Marx N, Hoffmann R,: Electrocardiographic and imaging predictors for permanent pacemaker requirement after transcatheter aortic valve implantation. The J Heart Valve Dis 2011; 20: 83-90.
14. Zahn R, Gerckens U, Grube E, Linke A, Sievert H, Eggebrecht H, Hambrecht R, Sack S, Hauptmann KE, Richardt G, Figulla HR, Senges J,; on behalf of the german German Transcatheter Aortic Valve Interventions-Registry Investigators: Transcatheter aortic valve implantation: First results from a multi-centre real-world registry. Eur Heart J 2011; 32: 198-204.
15. Baan J Jr,., Yong ZY, Koch KT, Henriques JPS, Bouma BJ, Vis MM, Cocchierei R, Piek JJ, de Mol BAJM,: Factors associated with cardiac conduction disorders and permanent pacemaker implantation after percutaneous aortic valve implantation with the CoreValve prosthesis. Am Heart J 2010; 159: 497-503.
16. Avanzas P, Munoz-Garcia AJ, Segura J, Pan M, Alonso-Briales JH, Lozano I, Moris C, De Lezo JS, Hernadez-Garcia JM,: Percutaneous implantation of the CoreValve self-expanding aortic valve prosthesis in patients with severe aortic stenosis: Early experience in Spain. Rev Esp Cardiol 2010; 63: 141-148.
17. Munoz-Garcia AJ, Hernandez-Garcia JM, Jimenez-Navarro MF, Alonso-Brigales JH, Rodriguez-Bailon I, Pena-Hernandez J, Fernandez-Pastor J, Dominguez-Franco AJ, Barrera-Cordero A, Alzueta-Rodriguez J, De Teresa GE,: Changes in atrioventricular conduction and predictors of pacemaker need after percutaneous implantation of the CoreValve aortic valve prosthesis. Rev Esp Cardiol 2010; 63: 1444-1451.
18. Taramasso M, Maisano F, Cioni M, Denti P, Godino C, Montorfano M, Colombo A, Alfieri O,: Trans-apical and trans-axillary percutaneous aortic valve implantation as alternatives to the femoral route: Short- and middle-term results. Eur J Cardiothorac Surg 2011; 40: 49-55.
19. Bekeredijan R, Krumsdorf U, Chorianopoulos E, Kallenbach K, Karck M, Katus HA, Rottbauer W,: Usefulness of percutaneous aortic valve implantation to improve quality of life in patients >80 years of age. Am J Cardiol 2010; 106: 1777-1781.
20. Bleiziffer S, Ruge H, Horer J, Hutter A, Geisbusch S, Brockmann G, Mazzitelli D, Bauernschmitt R, Lange R,: Predictors for new-onset complete heart block after transcatheter aortic valve implantation. JACC Cardiovasc Interv 2010; 3: 524-530.
21. Danenberg H, Finkelstein A, Kornowski R, Segev A, Dvir D, Gilon D, Keren G, Sagie A, Feinberg M, Schwammenthal E, Banai S, Lotan C, Guetta V,: Percutaneous implantation of the self-expandable CoreValve for high risk patients with severe aortic valve stenosis: Early Israeli experience. Isr Med Assoc J 2010; 12: 468-471.
22. Dworakowski R, MacCarthy PA, Monaghan M, Redwood S, El-Gamel A, Young C, Bapat V, Hancock J, Wilson K, Brickham B, Wendler O, Thomas MR,: Transcatheter aortic valve implantation for severe aortic stenosis-A new paradigm for multidisciplinary intervention: A prospective cohort study. Am Heart J 2010; 160: 237-243.
23. Eltchaninoff H, Prat A, Gilard M, Leguerrier A, Blanchard D, Fournial G, Lung B, Donzeau-Gouge P, Tribouilloy C, Debrux JL, Pavie A, Gueret P,; on behalf of the FRANCE Registry Investigators: Transcatheter aortic valve implantation: Early results of the FRANCE (FRench Aortic National CoreValve and Edwards) registry. Eur Heart J 2011; 32: 191-197.
24. Erkapic D, Kim WK, Weber M, Mollmann H, Berkowitsch A, Zaltsberg S, Pajitnev DJ, Rixe J, Neumann T, Kuniss M, Sperzel J, Hamm CW, Pitschner HF,: Electrocardiographic and further predictors for permanent pacemaker requirement after transcatheter aortic valve implantation. Europace 2010; 12: 1188-1190.
25. Ewe SH, Marsan NA, Pepi M, Delgado V, Tamborini G, Muratori M, Ng ACT, van der Kley F, de Weger A, Schalij MJ, Fusari M, Biglioli P, Bax JJ,: Impact of left ventricular systolic function on clinical and echocardiographic outcomes following transcatheter aortic valve implantation for severe aortic stenosis. Am Heart J 2010; 160: 1113-1120.
26. Godin M, Eltchaninoff H, Furuta A, Tron C, Anselme F, Bejar K, Sanchez-Giron C, Bauer F, Litzler PY, Bessou JP, Cribier A,: Frequency of conduction disturbances after transcatheter implantation of an Edwards Sapien aortic valve prosthesis. Am J Cardiol 2010; 106: 707-712.
27. Guinot PG, Depoix JP, Etchegoyen L, Benbara A, Provenchere S, Dilly MP, Philip I, Enguerand D, Ibrahim H, Vahanian A, Himbert D, Al-Attar N, Nataf P, Desmonts J-M, Montravers P, Longrois D,: Anesthesia and perioperative management of patients undergoing transcatheter aortic valve implantation: Analysis of 90 consecutive patients with focus on perioperative complications. J Cardiothorac Vasc Anesth 2010; 24: 752-761.
28. Latsios G, Gerckens U, Buellesfeld L, Mueller R, John D, Yuecel S, Syring J, Sauren B, Grube E,: "Device landing zone" calcification, assessed by MSCT, as a predictive factor for pacemaker implantation after TAVI. Catheter Cardiovasc Interv 2010; 76: 431-439.
29. Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR, Brown DL, Block PC, Guyton RA, Pichard AD, Bavaria JE, Herrmann HC, Douglas PS, Petersen JL, Akin JJ, Anderson WN, Wang D, Pocock S,; for the PARTNER Trial Investigators: Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 2010; 363: 1597-1607.
30. Rodes-Cabau J, Webb JG, Cheung A, Ye J, Dumont E, Feindel CM, Osten M, Natarajan MK, Velianou JL, Martucci G, DeVarennes B, Chisholm R, Peterson MD, Lichtenstein SV, Nietlispach F, Doyle D, DeLarochelliere R, Teoh K, Chu V, Dancea A, Lachapelle K, Cheema A, Latter D, Horlick E,: Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk: Acute and late outcomes of the multicenter Canadian experience. J Am Coll Cardiol 2010; 55: 1080-1090.
31. Roten L, Wenaweser P, Delacrétaz E, Hellige G, Stortecky S, Tanner H, Pilgrim T, Kadner A, Eberle B, Zwahlen M, Carrel T, Meier B, Windecker S,: Incidence and predictors of atrioventricular conduction impairment after transcatheter aortic valve implantation. Am J Cardiol 2010; 106: 1473-1480.
32. Tchetche D, Dumonteil N, Sauguet A, Descoutures F, Luz A, Garcia O, Soula P, Gabiache Y, Fournial G, Marcheix B, Carrie D, Fadajet J: Thirty-day outcome and vascular complications after transarterial aortic valve implantation using both Edwards Sapien and Medtronic CoreValve bioprostheses in a mixed population. EuroIntervention 2010; 5: 659-665.
33. Thomas M, Schymik G, Walther T,: Thirty-day results of the SAPIEN aortic Bioprosthesis European Outcome (SOURCE) Registry: A European registry of transcatheter aortic valve implantation using the Edwards Sapien valve. Circulation 2010; 122: 62-69.
34. Ussia GP, Scarabelli M, Mule M, Barbanti M, Cammalleri V, Imme S, Aruta P, Pistritto AM, Carbonaro A, Deste W, Sciuto P, Licciardello G, Calvi V, Tamburino C,: Postprocedural management of patients after transcatheter aortic valve implantation procedure with self-expanding bioprosthesis. Catheter Cardiovasc Interv 2010; 76: 757-766.
35. Walther T, Schuler G, Borger M, Kempfert J, Seeburger J, Ruckert Y, Ender J, Linke A, Scholz M, Falk V, Mohr FW,: Transapical aortic valve implantation in 100 consecutive patients: Comparison to propensity-matched conventional aortic valve replacement. Eur Heart J 2010; 31: 1398-1403.
36. Ye J, Cheung A, Lichtenstein S, Nietlispach F, Albugami S, Masson J-B, Thompson CR, Munt B, Moss R, Carere RG, Jamieson WR, Webb JG,: Transapical transcatheter aortic valve implantation: Follow-up to 3 years. J Thorac Cardiovasc Surg 2010; 139: 1107-1113.
37. Webb J, Altwegg L, Boone R, Cheung A, Ye J, Lichtenstein S, Lee M, Masson JB, Thompson C, Moss R, Carere R, Munt B, Nietlispach F, Humphries K,: Transcatheter aortic valve implantation: Impact on clinical and valve-related outcomes. Circulation 2009; 119: 3009-3016.
38. Piazza N, Onuma Y, Jesserun E, Kint PP, Maugenest A-M, Anderson RH, de Jaegere P, Serruys PW,: Early and persistent intraventricular conduction abnormalities and requirements for pacemaking after percutaneous replacement of the aortic valve. JACC Cardiovasc Interv 2008; 1: 310-316.
39. Piazza N, Grube E, Gerckens U, den Heijer P, Linke A, Luha O, Ramondo A, Ussia G, Wenaweser P, Windecker S, Laborde J-C, de Jaegere P, Serruys PW,: Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18 Fr) corevalve revalving system: Results from the multicentre, expanded evaluation registry 1-year following CE mark approval. EuroIntervention 2008; 4: 242-249.
40. Sinhal A, Altwegg L, Papsupati S, Humphries KH, Allrad M, Martin P, Cheung A, Ye J, Kerr C, Lichtenstein SV, Webb JG,: Atrioventricular block after transcatheter balloon expandable aortic valve implantation. JACC Cardiovasc Interv 2008; 1: 305-309.
41. Alam M, Dokainish H, Lakkis N,: Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: A systematic review of published studies. J Interv Cardiol 2006; 19: 319-327.
42. Lawrenz T, Lieder F, Bartelsmeier M, Leuner C, Borchert B, Meyer zu Vilsendorf D, Strunk-Mueller C, Reinhardt J, Feuchtl A, Stellbrink C, Kuhn H,: Predictors of complete heart block after transcoronary ablation of septal hypertrophy results of a prospective electrophysiological investigation in 172 patients with hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol 2007; 49: 2356-2363.
43. Chen AA, Palacios IF, Mela T, Yoerger DM, Picard MH, Vlahakes G, Lowry PA, Fifer MA,: Acute predictors of subacute complete heart block after alcohol septal ablation for obstructive hypertrophic cardiomyop-athy. Am J Cardiol 2006; 97: 264-269.
44. Talreja DR, Nishimura RA, Edwards WD, Valeti US, Ommen SR, Tajik AJ, Dearani JA, Schaff HV, Holmes DR Jr,: Alcohol septal ablation versus surgical septal myectomy: Comparison of effects on atrioventricular conduction tissue. J Am Coll Cardiol 2004; 21: 2329-2332.